267 related articles for article (PubMed ID: 35642087)
1. Drug repurposing against the RNA-dependent RNA polymerase domain of dengue serotype 3 by virtual screening and molecular dynamics simulations.
Gangopadhyay A; Saha A
J Biomol Struct Dyn; 2023 Jul; 41(11):5152-5165. PubMed ID: 35642087
[TBL] [Abstract][Full Text] [Related]
2. Exploring allosteric hits of the NS2B-NS3 protease of DENV2 by structure-guided screening.
Gangopadhyay A; Saha A
Comput Biol Chem; 2023 Jun; 104():107876. PubMed ID: 37141792
[TBL] [Abstract][Full Text] [Related]
3. Pharmacophore-Model-Based Drug Repurposing for the Identification of the Potential Inhibitors Targeting the Allosteric Site in Dengue Virus NS5 RNA-Dependent RNA Polymerase.
Kumar S; Bajrai LH; Faizo AA; Khateb AM; Alkhaldy AA; Rana R; Azhar EI; Dwivedi VD
Viruses; 2022 Aug; 14(8):. PubMed ID: 36016449
[TBL] [Abstract][Full Text] [Related]
4. Phenolic compounds of Theobroma cacao L. show potential against dengue RdRp protease enzyme inhibition by In-silico docking, DFT study, MD simulation and MMGBSA calculation.
Huq AKMM; Roney M; Dubey A; Nasir MH; Tufail A; Aluwi MFFM; Ishak WMW; Islam MR; Tajuddin SN
PLoS One; 2024; 19(3):e0299238. PubMed ID: 38483871
[TBL] [Abstract][Full Text] [Related]
5. Identification of FDA approved drugs against SARS-CoV-2 RNA dependent RNA polymerase (RdRp) and 3-chymotrypsin-like protease (3CLpro), drug repurposing approach.
Molavi Z; Razi S; Mirmotalebisohi SA; Adibi A; Sameni M; Karami F; Niazi V; Niknam Z; Aliashrafi M; Taheri M; Ghafouri-Fard S; Jeibouei S; Mahdian S; Zali H; Ranjbar MM; Yazdani M
Biomed Pharmacother; 2021 Jun; 138():111544. PubMed ID: 34311539
[TBL] [Abstract][Full Text] [Related]
6. Identification of RdRp inhibitors against SARS-CoV-2 through E-pharmacophore-based virtual screening, molecular docking and MD simulations approaches.
Rehman HM; Sajjad M; Ali MA; Gul R; Naveed M; Aslam MS; Shinwari K; Bhinder MA; Ghani MU; Saleem M; Rather MA; Ahmad I; Amin A
Int J Biol Macromol; 2023 May; 237():124169. PubMed ID: 36990409
[TBL] [Abstract][Full Text] [Related]
7. A crystal structure of the dengue virus non-structural protein 5 (NS5) polymerase delineates interdomain amino acid residues that enhance its thermostability and de novo initiation activities.
Lim SP; Koh JH; Seh CC; Liew CW; Davidson AD; Chua LS; Chandrasekaran R; Cornvik TC; Shi PY; Lescar J
J Biol Chem; 2013 Oct; 288(43):31105-14. PubMed ID: 24025331
[TBL] [Abstract][Full Text] [Related]
8. Identifying non-nucleoside inhibitors of RNA-dependent RNA-polymerase of SARS-CoV-2 through per-residue energy decomposition-based pharmacophore modeling, molecular docking, and molecular dynamics simulation.
Aziz S; Waqas M; Mohanta TK; Halim SA; Iqbal A; Ali A; Khalid A; Abdalla AN; Khan A; Al-Harrasi A
J Infect Public Health; 2023 Apr; 16(4):501-519. PubMed ID: 36801630
[TBL] [Abstract][Full Text] [Related]
9. A computational approach to drug repurposing against SARS-CoV-2 RNA dependent RNA polymerase (RdRp).
Ribaudo G; Ongaro A; Oselladore E; Zagotto G; Memo M; Gianoncelli A
J Biomol Struct Dyn; 2022 Feb; 40(3):1101-1108. PubMed ID: 32948103
[TBL] [Abstract][Full Text] [Related]
10. Allosteric ligands for the pharmacologically important Flavivirus target (NS5) from ZINC database based on pharmacophoric points, free energy calculations and dynamics correlation.
Khan A; Saleem S; Idrees M; Ali SS; Junaid M; Chandra Kaushik A; Wei DQ
J Mol Graph Model; 2018 Jun; 82():37-47. PubMed ID: 29677482
[TBL] [Abstract][Full Text] [Related]
11. Discovery of selective dengue virus inhibitors using combination of molecular fingerprint-based virtual screening protocols, structure-based pharmacophore model development, molecular dynamics simulations and in vitro studies.
Mirza SB; Lee RCH; Chu JJH; Salmas RE; Mavromoustakos T; Durdagi S
J Mol Graph Model; 2018 Jan; 79():88-102. PubMed ID: 29156382
[TBL] [Abstract][Full Text] [Related]
12. Identification of SARS-CoV-2 RNA dependent RNA polymerase inhibitors using pharmacophore modelling, molecular docking and molecular dynamics simulation approaches.
Pundir H; Joshi T; Pant M; Bhat S; Pandey J; Chandra S; Tamta S
J Biomol Struct Dyn; 2022; 40(24):13366-13377. PubMed ID: 34637693
[TBL] [Abstract][Full Text] [Related]
13. Virtual screening of eighteen million compounds against dengue virus: Combined molecular docking and molecular dynamics simulations study.
Mirza SB; Salmas RE; Fatmi MQ; Durdagi S
J Mol Graph Model; 2016 May; 66():99-107. PubMed ID: 27054972
[TBL] [Abstract][Full Text] [Related]
14. 25 (S)-Hydroxycholesterol acts as a possible dual enzymatic inhibitor of SARS-CoV-2 M
Alzahrani FA; Alkarim SA; Hawsawi YM; Abdulaal WH; Albiheyri R; Kurdi B; Alguridi H; El-Magd MA
J Biomol Struct Dyn; 2023 Jul; 41(10):4744-4755. PubMed ID: 35510619
[TBL] [Abstract][Full Text] [Related]
15. NS5 from Dengue Virus Serotype 2 Can Adopt a Conformation Analogous to That of Its Zika Virus and Japanese Encephalitis Virus Homologues.
El Sahili A; Soh TS; Schiltz J; Gharbi-Ayachi A; Seh CC; Shi PY; Lim SP; Lescar J
J Virol; 2019 Dec; 94(1):. PubMed ID: 31597763
[TBL] [Abstract][Full Text] [Related]
16. Probing the "fingers" domain binding pocket of Hepatitis C virus NS5B RdRp and D559G resistance mutation via molecular docking, molecular dynamics simulation and binding free energy calculations.
Manjula S; Sivanandam M; Kumaradhas P
J Biomol Struct Dyn; 2019 Jun; 37(9):2440-2456. PubMed ID: 30047829
[TBL] [Abstract][Full Text] [Related]
17. Repositioning of RdRp Inhibitors Against HCV NS5B Polymerase Utilizing Structure-Based Molecular Docking.
Tarannum H; Nandi S
Comb Chem High Throughput Screen; 2022; 25(4):702-719. PubMed ID: 33475069
[TBL] [Abstract][Full Text] [Related]
18. Allosteric inhibition of dengue virus RNA-dependent RNA polymerase by
Panday H; Jha SK; Al-Shehri M; Panda SP; Rana R; Alwathinani NF; Azhar EI; Dwivedi VD; Jha AK
J Biomol Struct Dyn; 2024 Jul; 42(10):5402-5414. PubMed ID: 38764132
[TBL] [Abstract][Full Text] [Related]
19. Finding potential inhibitors against RNA-dependent RNA polymerase (RdRp) of bovine ephemeral fever virus (BEFV): an
Pyasi S; Jonniya NA; Sk MF; Nayak D; Kar P
J Biomol Struct Dyn; 2022; 40(20):10403-10421. PubMed ID: 34238122
[TBL] [Abstract][Full Text] [Related]
20. Pharmacophore-based virtual screening and
Roney M; Huq AKMM; Issahaku AR; Soliman MES; Hossain MS; Mustafa AH; Islam MA; Dubey A; Tufail A; Mohd Aluwi MFF; Tajuddin SN
J Biomol Struct Dyn; 2023; 41(21):12186-12203. PubMed ID: 36645141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
